Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue:
Licensing revenue
Expenses:
Research and development		580		1,056
General and administrative	1,379,426	1,531,073	2,605,730	3,268,223
Total operating expenses	1,379,426	1,531,653	2,605,730	3,269,279
Loss before other income (expense)	(1,379,426)	(1,531,653)	(2,605,730)	(3,269,279)
Other income (loss):
Interest income	35,893	104,095	90,714	192,405
Interest expense
Other income (loss), net	2,043	14,968	740	(2,321)
Gain on warrant derivative liabilities
Net loss from continuing operations	(1,341,490)	(1,412,590)	(2,514,276)	(3,079,195)
Income from discontinued operations		138,095		378,712
Net loss	$ (1,341,490)	$ (1,274,495)	$ (2,514,276)	$ (2,700,483)
Basic and diluted loss per share
Continuing operations	$ (0.04)	$ (0.04)	$ (0.08)	$ (0.09)
Discontinued operations				0.01
Total basic and diluted loss per share	$ (0.04)	$ (0.04)	$ (0.08)	$ (0.08)
Basic and diluted weighted-average shares outstanding	33,508,302	33,249,904	33,508,302	33,249,904